Skin metastases from unknown origin:: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin

被引:17
作者
Azoulay, S [1 ]
Adem, C [1 ]
Pelletier, FLE [1 ]
Barete, S [1 ]
Francès, C [1 ]
Capron, F [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, Dept Anat Pathol, F-75634 Paris, France
关键词
D O I
10.1111/j.0303-6987.2005.00386.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Determining the primary origin of skin metastases might be a challenging issue for pathologists, especially when there is no primary history or when this history is unavailable. The poor specificity of morphological appreciation is challenging, emphasizing the need for ancillary studies. We have retrieved 44 cases of skin metastases from our pathology files. Paraffin blocks were collected and homemade tissue arrays were made. We have tried to assess the primary origin based on morphological data alone, and then using 13 antibodies (cytokeratins (CK) 5/6, 7, 19, 20, thyroid transcription factor-1, carcinoembryonic antigen, PS100, tumor-associated glycoprotein 72, BerEP4, estrogen receptor (ER), progesterone receptor (PR), CD10, and E-cadherin). Most metastases in our series were from breast (13) and colorectal cancers (six) as they are the main clinical activity in our hospital. Only 44% of cases were correctly assessed based on the sole morphology, emphasizing the need for ancillary studies. CK 20, ER, and PR were the most helpful markers to determine the primary origin of skin metastases by highlighting colorectal origin and mammary origin, respectively. By far, clinical information and morphological evaluation are more reliable than the use of ancillary techniques, which have to be used in the absence of the former one and the poor differentiation of the latter ones.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 14 条
[1]
Extensive cutaneous metastasis of transitional cell carcinoma of the bladder [J].
Akman, Y ;
Cam, K ;
Kavak, A ;
Alper, M .
INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (02) :103-104
[2]
BROWNSTEIN MH, 1972, CANCER-AM CANCER SOC, V29, P1298, DOI 10.1002/1097-0142(197205)29:5<1298::AID-CNCR2820290526>3.0.CO
[3]
2-6
[4]
Cytokeratin 20 immunoreactivity distinguishes merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites [J].
Chan, JKC ;
Suster, S ;
Wenig, BM ;
Tsang, WYW ;
Chan, JBK ;
Lau, ALW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (02) :226-234
[5]
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer [J].
Foulkes, WD ;
Stefansson, IM ;
Chappuis, PO ;
Bégin, LR ;
Goffin, JR ;
Wong, N ;
Trudel, M ;
Akslen, LA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) :1482-1485
[6]
Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract [J].
Kende, AI ;
Carr, NJ ;
Sobin, LH .
HISTOPATHOLOGY, 2003, 42 (02) :137-140
[7]
Leroy X, 1998, ANN PATHOL, V18, P103
[8]
CUTANEOUS METASTASES IN PATIENTS WITH METASTATIC CARCINOMA - A RETROSPECTIVE STUDY OF 4020 PATIENTS [J].
LOOKINGBILL, DP ;
SPANGLER, N ;
HELM, KF .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (02) :228-236
[9]
REINGOLD IM, 1966, CANCER, V19, P162, DOI 10.1002/1097-0142(196602)19:2<162::AID-CNCR2820190204>3.0.CO
[10]
2-A